However, a subset of cancer cells (about 10–15%) do not rely on telomerase activity but use a recombination-mediated alternative lengthening of telomere (ALT) mechanism (ALT cells) (Dunham et al. 2000) (Fig. 1, bottom panel). This evidence concerns the gene GPT and cancer.